Drug Company Gift Disclosure Act

Summary

Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require prescription drug manufacturers, packers, and distributors to annually disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made in connection with detailing, promotion, or other marketing activity to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person authorized to prescribe or dispense prescription drugs; and (2) cash rebates, discounts, or any other financial consideration given to any pharmaceutical benefit manager in connection with such marketing activities. Defines "gift" as any gift, fee, payment, subsidy, or other economic benefit with a value of $50 or more, except free samples of prescription drugs and the payment of reasonable compensation and reimbursement of expenses in connection with a bona fide clinical trial. Requires the Commissioner to: (1) make such information available to the public; and (2) keep confidential any information related to a trade secret. Establishes civil penalties for violations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 8 February 2006

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 8 February 2006

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 8 February 2006

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.